Practice Areas - Debt Capital Markets Law Firms and Lawyers
| Deal Date: | 09-06-2020 | Practice Area: | Debt Capital Markets |
| Deal Title: | Glaukos Corporation Convertible Senior Notes due 2027 | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced the pricing of its private offering of USD250 million aggregate principal amount of 2.75% Convertible Senior Notes due 2027. The offering size was increased from the previously announced offering size of USD200 million aggregate principal amount of notes. The notes were offered only to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended.
Latham and Watkins LLP represented the initial purchasers in the offering.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Latham & Watkins |
| Issuer Jurisdiction: | United States | Listing Jurisdiction: | United States |
| Classification: |
Equity-Linked Securities Convertible Bonds |
Lawyer | Witold Balaban |
